Heyman Richard A. sold ELVN
January 8, 2026 · Form 4 insider transaction
Heyman Richard A. sold 1,620 shares of Enliven Therapeutics, Inc. at $25.00 per share, a transaction worth $40.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,620
Price
$25.00
Total value
$40.5K
InsiderHeyman Richard A.
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 8, 2026
Filing dateJanuary 12, 2026
Shares owned after25,545
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024 by RAHD Capital LLC, for which the Reporting Person serves as a managing member.; The shares are held of record by RAHD Capital LLC.